Please select an option below to help us tailor your newsletter to best suit your content interests!
Here at West, we believe that diversity, equity, and inclusion are critical to reducing cancer disparities. On Friday, March 3, Dr. Gregory Vidal led a workshop called “Conversations for Change” aimed to encourage conversations about prevention, diagnosis, and treatment of cancer to primary care providers in our community. Discussions included: – Diagnostic Standards… Read more »
Our West family is excited to host the upcoming “Diversity, Equity, and Inclusion Conversations for Change” on Friday, March 3. Aimed to improve pathways for care and end disparities in our area, Dr. Gregory Vidal and several fellow West providers invite primary care providers to this collaborative meeting. Topics include: – Barriers to Access of Cancer Care… Read more »
Diversity, equity, and inclusion are critical to reducing cancer disparities. We believe everyone should have the ability to benefit from advancements in the prevention, diagnosis, and treatment of cancer. West Medical Oncologist, Dr. Gregory Vidal, will be hosting a “Conversation for Change” on Friday, March 3 for Primary Care Providers to discuss: – Diagnostic Standards for… Read more »
“Women undergoing treatment for breast cancer require frequent clinic visits for maintenance of therapy. With COVID-19 causing health care disruptions, it is important to learn about how this population’s access to health care has changed.” The study linked below was co-authored by two of our very own – Dr. Gregory Vidal and Andrea Curry, and compares self-reported… Read more »
The West Cancer Foundation recently sat down with Dr. Greg Vidal to talk about #breastcancer disparities. A 2014 study funded by the AVON Foundation discovered that Memphis had the highest national rate of breast cancer disparities among black women. They were dying of breast cancer at two times the rate of white women. Since this… Read more »
West Cancer Center, Memphis, Tennessee; City of Hope Comprehensive Cancer Center, Duarte, California; Mays Cancer Center, home to UT Health San Antonio MD Anderson, San Antonio, Texas; O’Neal Comprehensive Cancer Center, and University of Alabama at Birmingham, Birmingham, Alabama; comprise the new Advancing Inclusive Research® Site Alliance. This coalition of clinical research sites aims to advance the representation… Read more »
Gregory Vidal, MD, PhD, West Cancer Center and Research Institute, discusses the methodology of the Neat-HER study on neratinib in the extended adjuvant setting in HER2-positive breast cancer. Gregory Vidal, MD, PhD, of West Cancer Center and Research Institute, discusses the methodology of the Neat-HER study on neratinib in the extended adjuvant setting in… Read more »